INTRODUCTION
Asymptomatic bacteriuria (ASB) and urinary tract
infection (UTI) are among the most common diagnoses
worldwide. Particularly in special patient
groups such as women with diabetes mellitus and
pregnant women, complications can have far-reaching
consequences such as pyelonephritis or adverse
effects for the neonate. Moreover, UTIs may present
differently in diabetic and pregnant women owing
to disparities in underlying pathogenesis or causative
uropathogens. This review provides an overview
of the most recent clinical studies of interest (published
from 2012 till now) concerning epidemiology,
risk factors, consequences and treatment of UTI
and ASB in diabetic and pregnant women.